peptide name for tirzepatide PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: Order Tirzepatide (100 mg) |
Description
Staying on 2.5mg for 3-4 months when side effects remain minimal wastes time at suboptimal doses

For full prescribing information, please refer to the Summary of Product Characteristics on medicines.org.uk

It is designed for extended protocols or higher-dose research where going through multiple smaller vials becomes impractical

Tirzepatide is typically started at a dose of 2.5 mg, administered once a week as a subcutaneous injection

The SURMOUNT-4 follow-up analysis, published in JAMA Internal Medicine in 2025, found that weight regain after stopping tirzepatide was associated with reversal of improvements in blood pressure, blood glucose, cholesterol, and insulin sensitivity
How does Tirzepatide compare to other weight loss medications
